Astrana Health (ASTH) Receivables (2011 - 2026)

Astrana Health has reported Receivables for 16 years, with the latest figure at $495.4 million in Q1 2026.

• Quarterly Receivables rose 609.84% year-over-year to $495.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $495.4 million (up 609.84% YoY) and the FY2025 annual result came in at $400.8 million, up 31.22% from the prior year.
• Receivables grew to $495.4 million in Q1 2026 per ASTH's latest filing, from $400.8 million in the prior quarter.
• Over five years, Receivables peaked at $495.4 million in Q1 2026 and troughed at $14.3 million in Q1 2022.
• A 5-year average of $163.4 million and a median of $97.4 million in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2023 and 2024: Receivables jumped 957.56% in 2023, then slumped 67.56% in 2024.
• Over 5 years, Receivables stood at $22.2 million in 2022, then surged by 172.98% to $60.7 million in 2023, then jumped by 309.12% to $248.3 million in 2024, then jumped by 61.42% to $400.8 million in 2025, then rose by 23.59% to $495.4 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $495.4 million, $400.8 million, and $391.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.